SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

HIQ HITIQ Limited

Healthcare · Health Information Services · website
$0.01
52wk 0.00 – 0.04
Overall
23.9
Value
91.6
Growth
15.7
Health
0.0
Quality
0.0
Momentum
0.6
Dividend
—
Price
About HITIQ Limited

HITIQ Limited, together with its subsidiaries, develops and commercializes concussion management technology in Oceania. The company offers smart mouthguards and software for sports, clinical, and research applications. It also provides PROTEQT, a smart mouthguard with sensor technology to detect, assess, and manage potential head impacts, as well as a concussion management app, replacement parts, and charger kits; ConneQt, an integrated ecosystem linking team administrators, caregivers, and players to medical professionals following a potential concussive event; and Nexus, a data analysis platform to view drill, position, team and player-based data. HITIQ Limited was incorporated in 2015 and is headquartered in Melbourne, Australia.

Price analytics

Returns

1 day 11.1%
1 week 0.0%
1 month 0.0%
3 months -16.7%
6 months -66.7%
1 year -76.2%
3 years -72.2%

Risk

Volatility (1y ann.) 198.7%
Beta vs ASX 200 1.61
Sharpe (1y) 0.14
VaR 95% (1-day) -16.7%
Max drawdown (1y) -85.7%
Off 1-year high -82.1%

Technicals

RSI(14) 60
vs 50DMA -12.7%
vs 200DMA -56.1%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 91.6
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
69
Growth 15.7
Revenue growth (1y)
0
Revenue CAGR (3y)
31
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 0.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
0
Debt / Equity
—
Quality (Profitability & Cash Flow) 0.0
Return on equity
—
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 0.6
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
3

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$5.79M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
-0.67
EV / EBITDA
-1.84
Price / Book
-0.62
ROE
—
Operating margin
-476.1%
Net margin
0.0%
Total cash
$173,638
Total debt
$5.85M
Current ratio
0.18
Debt / Equity
—
Free cash flow
$-2.12M
Avg volume
1.65M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$673.25K
  • Gross profit$673.25K
  • Operating income-$7.55M
  • Net income-$7.21M
  • Diluted EPS-0.02
  • Free cash flow-$4.68M
  • Net debt$4.67M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4